052020 Stock Chart & Stats
₩7430.00
₩0.00(0.00%)
―
--
Day’s Range― - ―
52-Week Range₩6,810.00 - ₩22,500.00
Previous CloseN/A
VolumeN/A
Average Volume (3M)261.57K
Market Cap
₩491.16B
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.08
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding67,983,290
10 Day Avg. Volume184,912
30 Day Avg. Volume261,567
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
052020 FAQ
What was STCube, Inc.’s price range in the past 12 months?
STCube, Inc. lowest stock price was ₩6810.00 and its highest was ₩22500.00 in the past 12 months.
What is STCube, Inc.’s market cap?
STCube, Inc.’s market cap is ₩491.16B.
When is STCube, Inc.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were STCube, Inc.’s earnings last quarter?
Currently, no data Available
Is STCube, Inc. overvalued?
According to Wall Street analysts STCube, Inc.’s price is currently Undervalued.
Does STCube, Inc. pay dividends?
STCube, Inc. does not currently pay dividends.
What is STCube, Inc.’s EPS estimate?
STCube, Inc.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does STCube, Inc. have?
STCube, Inc. has 67,983,290 shares outstanding.
What happened to STCube, Inc.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of STCube, Inc.?
Currently, no hedge funds are holding shares in KR:052020
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
STCube, Inc.
Stcube Inc operates as a biopharmaceutical enterprise, specializing in the development of medical treatments. Their work specifically addresses the novel strategies cancer employs to bypass the body's immune defenses, with a particular focus on the Korean market.
Pharmicell Co., Ltd
―
Bioneer Corporation
―
ToolGen Incorporated
―
Genomictree, Inc.
―
Prestige BioPharma Limited Korean Deposit Receipt Repr 1/5 Sh
―